Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Am...

FDA Recall #D-0319-2024 — Class II — January 15, 2024

Recall #D-0319-2024 Date: January 15, 2024 Classification: Class II Status: Terminated

Product Description

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Recalling Firm

Amneal Pharmaceuticals of New York, LLC — Brookhaven, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

858 bottles

Distribution

USA nationwide.

Code Information

Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated